Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil)
Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil) 07-Nov-2022 / 07:00 CET/CEST Release
Switzerland General Irina Koffler Raghuram Ram Selvaraju Jack Weinstein Exchange Commission Relief Therapeutics Holding Sa Key
Source: finanznachrichten.de